跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 117 条关于
“Tie2”
全部
117
临床试验
67
药物
10
机构
4
资讯
36
3个月前
Ingenia Therapeutics Receives KRX Approval for IPO as TIE2-Targeted Therapies Advance to Phase 3
去年
PharmAbcine's PMC-403 Receives Safety Approval for 4mg Single-Dose Cohort in Phase 1 AMD Trial
去年
Longeveron's Lomecel-B Shows Promise in Mild Alzheimer's Disease by Targeting MMP14
去年
Vasomune to Present Late-Breaking Data on AV-001's Protective Effects Against COVID-19 at ATS Conference
5个月前
Merck Initiates Pivotal Phase 2b/3 Trial for Novel Bispecific Antibody MK-8748 in Wet Age-Related Macular Degeneration
12个月前
Phase 1 HELIOS Trial Shows Promise for OTX-TKI in Diabetic Retinopathy Treatment
去年
Genenta Science's Temferon Receives Approval for Phase 1 Trial in Metastatic Renal Cell Carcinoma
3个月前
Notch2 and CXCR4 Identified as Key Drivers of Breast Cancer Dormancy in Bone Marrow
去年
Aerpio Initiates Phase 2 Trial of Razuprotafib for COVID-19 Blood Vessel Damage
去年
Deciphera's Qinlock Fails Phase 3 Trial in Second-Line GIST, Shares Plummet 75%
第 1 页,共 4 页
上一页
下一页